State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Pediatric Dentistry, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, People's Republic of China.
Department of Stomatology, Joint Logistics Support Force of the Chinese People's Liberation Army, Hohhot, Inner Mongolia 010000, People's Republic of China.
Stem Cells. 2024 Oct 9;42(10):914-927. doi: 10.1093/stmcls/sxae051.
This study aims to address challenges in dental pulp regeneration therapy. The heterogeneity of DPSCs poses challenges, especially in stem cell transplantation for clinical use, particularly when sourced from donors of different ages and conditions.
Pseudotime analysis was employed to analyze single-cell sequencing data, and immunohistochemical studies were conducted to investigate the expression of fibronectin 1 (FN1). We performed in vitro sorting of PDGFRβ+ DPSCs using flow cytometry. A series of functional assays, including cell proliferation, scratch, and tube formation assays, were performed to experimentally validate the vasculogenic capabilities of the identified PDGFRβ+ DPSC subset. Furthermore, gene-edited mouse models were utilized to demonstrate the importance of PDGFRβ+ DPSCs. Transcriptomic sequencing was conducted to compare the differences between PDGFRβ+ DPSCs and P1-DPSCs.
Single-cell sequencing analysis unveiled a distinct subset, PDGFRβ+ DPSCs, characterized by significantly elevated FN1 expression during dental pulp development. Subsequent cell experiments demonstrated that this subset possesses remarkable abilities to promote HUVEC proliferation, migration, and tube formation. Gene-edited mouse models confirmed the vital role of PDGFRβ+ DPSCs in dental pulp development. Transcriptomic sequencing and in vitro experiments demonstrated that the PDGFR/PI3K/AKT signaling pathway is a crucial factor mediating the proliferation rate and pro-angiogenic properties of PDGFRβ+ DPSCs.
We defined a new subset, PDGFRβ+ DPSCs, characterized by strong proliferative activity and pro-angiogenic capabilities, demonstrating significant clinical translational potential.
本研究旨在解决牙髓再生治疗中的挑战。牙髓间充质干细胞(DPSCs)的异质性是一个挑战,特别是在干细胞移植用于临床应用时,尤其是当来源不同年龄和条件的供体时。
采用拟时分析对单细胞测序数据进行分析,并通过免疫组织化学研究调查纤维连接蛋白 1(FN1)的表达。我们使用流式细胞术对 PDGFRβ+DPSCs 进行体外分选。进行了一系列功能测定,包括细胞增殖、划痕和管形成测定,以实验验证鉴定的 PDGFRβ+DPSC 亚群的血管生成能力。此外,还利用基因编辑小鼠模型证明了 PDGFRβ+DPSCs 的重要性。进行转录组测序以比较 PDGFRβ+DPSCs 和 P1-DPSCs 之间的差异。
单细胞测序分析揭示了一个独特的亚群,即 PDGFRβ+DPSCs,其在牙髓发育过程中 FN1 的表达显著升高。随后的细胞实验表明,该亚群具有显著促进 HUVEC 增殖、迁移和管形成的能力。基因编辑小鼠模型证实了 PDGFRβ+DPSCs 在牙髓发育中的重要作用。转录组测序和体外实验表明,PDGFR/PI3K/AKT 信号通路是介导 PDGFRβ+DPSCs 增殖率和促血管生成特性的关键因素。
我们定义了一个新的亚群,即 PDGFRβ+DPSCs,其具有强大的增殖活性和促血管生成能力,具有显著的临床转化潜力。